Dr. Webster serves as Managing Director and Chief Executive Officer of Demerix Ltd (ASX: DXB), a clinical-stage biopharmaceutical company, developing a portfolio of drugs to treat inflammatory diseases. Formerly the Commercial Director for Acrux Limited (ASX: ACR) and Director of Commercialisation and Intellectual Property for Immuron Limited (ASX: IMC) she brings to IBX vast experience in investor relations, strategic planning, and scientific and operational execution. She holds a Ph.D in Pharmaceutics, a Bachelor degree in Pharmacology, a Masters degree in Intellectual Property Law and an Executive MBA and currently also serves as Non-Executive Chairperson for SYNthesis BioVentures and as Non-Executive Director for Linear Clinical Research Limited.
Employee Spotlight: Dan Inglese, Research Associate
April 12, 2022
Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems: What experience do you bring prior to joining IB? I